Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Central Clinic
    3. >
  3. Kidney Transplant Center

Journal
Presentation
    （Last updated : 2023-03-24 15:08:55）
  Nanami Masayoshi
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Dysregulated iron metabolism in patients on hemodialysis. 2015/05
2. Original article　 Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited. 2015/07
3. Original article　 Pendrin gene ablation alters ENaC subcellular distribution and open probability. 2015/07
4. Original article　 ENaC inhibition stimulates HCl secretion in the mouse cortical collecting duct. I. Stilbene-sensitive Cl- secretion 2015/08
5. Original article　 ENaC inhibition stimulates HCl secretion in the mouse cortical collecting duct. II. Bafilomycin-sensitive H+ secretion. 2015/08
6. Original article　 Iron localization and infectious disease in chronic kidney disease patients. 2016/04
7. Original article　 Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited. 2016/10
8. Original article　 Interplay of adipocyte and hepatocyte: Leptin upregulates hepcidin. 2018/01
9. Original article　 Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with/without TNF-alpha. 2018/01
10. Original article　 The role of intercalated cell nedd4-2 in BP regulation, ion transport, and transporter expression. 2018/06
11. Original article　 Oral versus intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis-effect on fibroblast growth factor-23 metabolism. 2018/07
12. Original article　 Fludrocortisone stimulates erythropoietin production in the intercalated cells of the collecting ducts. 2018/09
13. Original article　 Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease. 2019/01
14. Original article　 Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention. 2019/01
15. Original article　 Misdistribution of iron and oxidative stress in chronic kidney disease. 2019/03
16. Original article　 Current Topics in Vascular Access: Superficialization of Arteriovenous Fistula. 2019/04
17. Introduction　 The pathogenesis of CKD complications; Attack of dysregulated iron and phosphate metabolism. 2020/09
18. Original article　 Efficacy of aerobic exercise on the cardiometabolic and renal outcomes in patients with chronic kidney disease: a systematic review of randomized controlled trials. 2021/02
19. Original article　 Melatonin and gestational hypertension. 2021/11
20. Original article　 Hemodiafiltration improves low levels of health-related quality of life (Qol) and nutritional conditions of hemodialysis patients. 2022/02
21. Original article　 Long-acting erythropoiesis-stimulating agent (ESA) induces physiological erythropoiesis via improvement of iron availability. 2022/05
Display 5 items
Display all(21)
■ Presentation
1. Hb levels and dose of iron associated with adverse events are different between younger and elderly hemodialysis patients  2016/05/22
2. Pathophysiology of anemia in a mouse model of chronic kidney disease ; hepcidin and erythropoiesis  2016/05/22
3. Aldosterone and vasopressin are erythropoietic hormones  2016/11/18
4. Comparison of Hb levels and dose of iron associated with adverse events between younger and elderly hemodialysis patients  2016/11/19
5. Dysregulated iron metabolism in bone marrow of a mouse model of chronic kidney disease  2016/11/19
6. The association between dialysis session time and the risk for hospitalization and death in maintenance hemodialysis  2016/11/19
7. Iron stimulation enhanced calcification in human vascular smooth muscle cells.  2017/06/04
8. The impact of dose of ESA and iron on the risk of adverse events of hemodialysis patients.  2017/06/04
9. Dysregulated erythroid differentiation and iron metabolism in anemia of chronic kidney disease(CKD).  2017/06/05
10. An impairment of the coagulation-fibrinolysis system implicates vascular access patency in patients on hemodialysis after vascular access intervention.  2017/11/03
11. Fludrocortisone time-dependently up-regulates erythropoietin(Epo) mRNA expression via HIF2α pathway in rat kidney.  2017/11/04
12. Fibroblast Growth Factor-23 Is Related With Bone Mineral Content Of End Stage Renal Disease Patients On Haemodialysis.  2018/05/25
13. Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24(IL-24).  2018/05/25
14. Zinc Deficiency is a Risk for Vascular Access Failure in Hemodialysis Patients.  2018/10/26
15. Iron stimulation calcification in human aortic vascular smooth muscle cells through interleukin-24(IL-24).  2018/10/27
16. Prevalence of Triglyceride deposit cardiomyovasculopathy in chronic kidney disease patients  2019/03/16
17. Predilution on-line hemodiafiltration improves health-related quality of life (HRQoL) in the patients undergoing hemodialysis.  2019/06/14
18. Prevalence of periodontal disease bacteria in tonsils of IgA nephropathy patients.  2019/06/14
19. Prevalence of triglyceride deposit cardiomyovasculopathy in chronic kidney disease patients.  2019/06/14
20. Zinc deficiency may implicate vascular access failure after vascular access intervention in haemodialysis patients.  2019/06/14
21. Intravenous streptcoccus mutans in rats induced glomeloronephlitis like IgA nephropathy or infection-related glomerulonephritis.  2019/06/15
22. Long-acting erythropoiesis-stimulating agent (ESA) induced the physiological erythropoiesis via improvemen of iron availability.  2019/06/15
23. Polymorphism in the human matrix gla protein gene Is associated with the progression of osteoporosis in hemodialysis patients  2019/11/07
24. Dental caries induced by CNM-positive streptococcus mutans derived from IgA nephropathy patients in rats induced gloperulonephritis like IgA nephropathy.  2020/06/06
25. The correlation between the management of comorbidities and the progression of the renal dysfunction or adverse events of chronic kidney disease.  2020/06/06
26. The effect of smoking upon CKD in a Japanese nationwide 6-years follow up servey.  2020/06/06
Display 5 items
Display all(26)
mail